Voyager Therapeutics - 53 Year Dividend History | VYGR
Historical dividend payout and yield for Voyager Therapeutics (VYGR) since 1971. The current TTM dividend payout for Voyager Therapeutics (VYGR) as of November 19, 2024 is $0.00. The current dividend yield for Voyager Therapeutics as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.288B |
$0.250B |
|
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
